BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Terfenadine: closer monitoring of the side-effect profile

Active substance: terfenadine

After a hearing regarding terfenadine, including evaluation of the safety report, no changes in the benefit/risk profile could be determined.

To the risk assessment procedure (available in German only)

Risikoinfo_Downloadtitel_Risikobewertungsverfahren , Download_VeroeffentlichtAm_EN PDF, 77KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK